BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12529174)

  • 1. Protein-protein interactions involved in the recognition of p27 by E3 ubiquitin ligase.
    Xu K; Belunis C; Chu W; Weber D; Podlaski F; Huang KS; Reed SI; Vassilev LT
    Biochem J; 2003 May; 371(Pt 3):957-64. PubMed ID: 12529174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase.
    Hao B; Zheng N; Schulman BA; Wu G; Miller JJ; Pagano M; Pavletich NP
    Mol Cell; 2005 Oct; 20(1):9-19. PubMed ID: 16209941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27.
    Ganoth D; Bornstein G; Ko TK; Larsen B; Tyers M; Pagano M; Hershko A
    Nat Cell Biol; 2001 Mar; 3(3):321-4. PubMed ID: 11231585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three different binding sites of Cks1 are required for p27-ubiquitin ligation.
    Sitry D; Seeliger MA; Ko TK; Ganoth D; Breward SE; Itzhaki LS; Pagano M; Hershko A
    J Biol Chem; 2002 Nov; 277(44):42233-40. PubMed ID: 12140288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2).
    Mamillapalli R; Gavrilova N; Mihaylova VT; Tsvetkov LM; Wu H; Zhang H; Sun H
    Curr Biol; 2001 Feb; 11(4):263-7. PubMed ID: 11250155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A negatively charged amino acid in Skp2 is required for Skp2-Cks1 interaction and ubiquitination of p27Kip1.
    Wang W; Ungermannova D; Chen L; Liu X
    J Biol Chem; 2003 Aug; 278(34):32390-6. PubMed ID: 12813041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput screening for inhibitors of the Cks1-Skp2 interaction.
    Huang KS; Vassilev LT
    Methods Enzymol; 2005; 399():717-28. PubMed ID: 16338391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate recognition and ubiquitination of SCFSkp2/Cks1 ubiquitin-protein isopeptide ligase.
    Xu S; Abbasian M; Patel P; Jensen-Pergakes K; Lombardo CR; Cathers BE; Xie W; Mercurio F; Pagano M; Giegel D; Cox S
    J Biol Chem; 2007 May; 282(21):15462-70. PubMed ID: 17409098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of cullin-1 by ubiquitin-like protein Nedd8 enhances the activity of SCF(skp2) toward p27(kip1).
    Morimoto M; Nishida T; Honda R; Yasuda H
    Biochem Biophys Res Commun; 2000 Apr; 270(3):1093-6. PubMed ID: 10772955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation.
    Appleman LJ; Chernova I; Li L; Boussiotis VA
    Cell Cycle; 2006 Sep; 5(18):2123-9. PubMed ID: 16969077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer.
    Pavlides SC; Huang KT; Reid DA; Wu L; Blank SV; Mittal K; Guo L; Rothenberg E; Rueda B; Cardozo T; Gold LI
    Endocrinology; 2013 Nov; 154(11):4030-45. PubMed ID: 24035998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitination of p27Kip1 requires physical interaction with cyclin E and probable phosphate recognition by SKP2.
    Ungermannova D; Gao Y; Liu X
    J Biol Chem; 2005 Aug; 280(34):30301-9. PubMed ID: 15980415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.
    Lin R; Wang TT; Miller WH; White JH
    Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput screening AlphaScreen assay for identification of small-molecule inhibitors of ubiquitin E3 ligase SCFSkp2-Cks1.
    Ungermannova D; Lee J; Zhang G; Dallmann HG; McHenry CS; Liu X
    J Biomol Screen; 2013 Sep; 18(8):910-20. PubMed ID: 23589337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
    Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
    Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication.
    Nakayama K; Nagahama H; Minamishima YA; Matsumoto M; Nakamichi I; Kitagawa K; Shirane M; Tsunematsu R; Tsukiyama T; Ishida N; Kitagawa M; Nakayama K; Hatakeyama S
    EMBO J; 2000 May; 19(9):2069-81. PubMed ID: 10790373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2): evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway.
    Lisztwan J; Marti A; Sutterlüty H; Gstaiger M; Wirbelauer C; Krek W
    EMBO J; 1998 Jan; 17(2):368-83. PubMed ID: 9430629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
    Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
    Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.
    Spruck C; Strohmaier H; Watson M; Smith AP; Ryan A; Krek TW; Reed SI
    Mol Cell; 2001 Mar; 7(3):639-50. PubMed ID: 11463388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer.
    Huang KT; Pavlides SC; Lecanda J; Blank SV; Mittal KR; Gold LI
    PLoS One; 2012; 7(9):e46072. PubMed ID: 23029392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.